Monkfruit turns out to be more than sweet, it’s packed with hidden compounds linked to health.

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...

Endometriosis is a prevalent yet underdiagnosed disease affecting a large population of women of reproductive age, with a ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

The overall sentiment of these big-money traders is split between 42% bullish and 50%, bearish. Out of all of the options we uncovered, there was 1 put, for a total amount of $27,360, and 13, calls, ...

DelveInsight's PSMA-targeted Therapy Market Size, Target Population, Competitive Landscape & Market Forecast report includes ...

Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...

IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

The CHB therapeutics market offers growth opportunities via emerging functional cures like bepirovirsen and selgantolimod, amidst challenges from patent expiries and generic erosion. Strategic R&D, ...

January 2026 Consumer Search Analysis Examines How Shoppers Evaluate Single-Ingredient vs Multi-Ingredient Berberine ...

Biomea Fusion (NASDAQ:BMEA) highlighted two clinical-stage programs focused on diabetes and obesity during a presentation at ...